Latest Breaking News On - Opexa therapeutics - Page 1 : comparemela.com

Monopar Announces CFO Succession

Monopar Announces CFO Succession
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesChandler robinsonKimr tsuchimotoKarthik radhakrishnanMonopartx linkedinAsylia therapeutics incSantalis pharmaceuticals incMonopar therapeutics incOpexa therapeutics incTitania partnersExchange commissionChief financial officerEffective julyPrincipal accounting officerPrincipal financial

Monopar Therapeutics Inc Announces CFO Changes

Monopar Therapeutics Inc Announces CFO Changes
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesKarthik radhakrishnanKimr tsuchimotoMonopar therapeutics incOpexa therapeutics incSantalis pharmaceuticals incTitania partnersAsylia therapeutics incMonopar therapeuticsChief financial officerEffective julyPrincipal accounting officerPrincipal financialSantalis pharmaceuticalsChief executive officer

NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO

Announces senior leadership appointments to further support client programs and growing sales pipelineDURHAM, N.C., Jan. 08, 2024 NightHawk Biosciences , an integrated contract development and.

United statesSan antonioBrian omaraJeff wolfCatalent biologicsAnia szymanskaSteve lavezoliDavid waldmanMarker therapeutics incQuality validation specialists of opexa therapeutics incCompany to scorpius holdings incQuality control for bellicum pharmaceuticals incUniversity of warsawBristol myers squibbBusiness market developmentSuspension process development at rocket pharmaceuticals

ProMIS Neurosciences Inc : ProMIS Neurosciences, Inc Announces Leadership Transition

ProMIS Neurosciences Inc : ProMIS Neurosciences, Inc Announces Leadership Transition
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesGene williamsUniversity of torontoCompany board of directorsBiopharma incUniversity of trinity collegeGenexine incSchulich school of business at york universityPromis neurosciences incExchange commissionNeil warmaChief executive officerGail farfelOpexa therapeuticsI mab biopharma

Neuromyelitis Optica Spectrum Disorder Market to grow by USD 173 48 million from 2022 to 2027 | The growing geriatric population drives growth

/PRNewswire/ The neuromyelitis optica spectrum disorder market to grow by USD 173.48 million at a CAGR of 6.16% from 2022 to 2027, according to the latest.

United kingdomUnited statesJesse maidaTg therapeutics incHorizon therapeutics plcCompany offeringsTechnavio researchChugai pharmaceutical coCompany landscapeOpexa therapeutics incMitsubishi chemical group corpBiogen incF hoffmann la roche ltdHoldings ltdNorth americaDiscover pharmaceuticals